These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 36669700)
21. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin. Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445 [TBL] [Abstract][Full Text] [Related]
22. MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells. Shi W; Hou X; Peng H; Zhang L; Li Y; Gu Z; Jiang Q; Shi M; Ji Y; Jiang J Virol J; 2014 Dec; 11():227. PubMed ID: 25548009 [TBL] [Abstract][Full Text] [Related]
23. Discovery of 3-benzyl-1,3-benzoxazine-2,4-dione analogues as allosteric mitogen-activated kinase kinase (MEK) inhibitors and anti-enterovirus 71 (EV71) agents. Sun J; Niu Y; Wang C; Zhang H; Xie B; Xu F; Jin H; Peng Y; Liang L; Xu P Bioorg Med Chem; 2016 Aug; 24(16):3472-82. PubMed ID: 27288186 [TBL] [Abstract][Full Text] [Related]
24. Hederacolchiside C inhibits Enterovirus 71 propagation through activating innate immunity. Wang YE; Kang NX; Zhao JP; Liu YL; Li KP; Xu QM; Khan IA; Yang S J Infect Chemother; 2019 Dec; 25(12):1074-1077. PubMed ID: 31401030 [TBL] [Abstract][Full Text] [Related]
25. A Novel Murine Model Expressing a Chimeric mSCARB2/hSCARB2 Receptor Is Highly Susceptible to Oral Infection with Clinical Isolates of Enterovirus 71. Yang CH; Liang CT; Jiang ST; Chen KH; Yang CC; Cheng ML; Ho HY J Virol; 2019 Jun; 93(11):. PubMed ID: 30894476 [TBL] [Abstract][Full Text] [Related]
26. [Detection of cerebrospinal fluid anti-enterovirus 71 IgM in children with severe hand, food and mouth disease induced by enterovirus 71 infection and its clinical significance]. Wu Y; Chen D; Zhou J; Wang J; Zhao S; Shao Q; Wei Y Zhonghua Er Ke Za Zhi; 2015 May; 53(5):355-9. PubMed ID: 26080665 [TBL] [Abstract][Full Text] [Related]
27. Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in Zhejiang Province, China. Wu H; Xue M; Wu C; Lu Q; Ding Z; Wang X; Fu T; Yang K; Lin J PLoS One; 2022; 17(9):e0274421. PubMed ID: 36126038 [TBL] [Abstract][Full Text] [Related]
28. Activation of Host Cellular Signaling and Mechanism of Enterovirus 71 Viral Proteins Associated with Hand, Foot and Mouth Disease. Swain SK; Panda S; Sahu BP; Sarangi R Viruses; 2022 Oct; 14(10):. PubMed ID: 36298746 [TBL] [Abstract][Full Text] [Related]
29. Studies on Inhibition of Proliferation of Enterovirus-71 by Compound YZ-LY-0. Yang Q; Jie Q; Shaw N; Li L; Rao Z; Yin Z; Lou Z Int J Biol Sci; 2015; 11(11):1337-47. PubMed ID: 26640412 [TBL] [Abstract][Full Text] [Related]
30. Pathogenesis Study of Enterovirus 71 Using a Novel Human SCARB2 Knock-In Mouse Model. Jin Y; Sun T; Zhou G; Li D; Chen S; Zhang W; Li X; Zhang R; Yang H; Duan G mSphere; 2021 Mar; 6(2):. PubMed ID: 33692197 [TBL] [Abstract][Full Text] [Related]
31. Antiviral effects of Retro-2 Dai W; Wu Y; Bi J; Lu X; Hou A; Zhou Y; Sun B; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C Antiviral Res; 2017 Aug; 144():311-321. PubMed ID: 28688753 [TBL] [Abstract][Full Text] [Related]
32. Enterovirus 71 induces autophagy in mice via mTOR inhibition and ERK pathway activation. Wang B; Zhu Y; Liu L; Wang B; Chen M; Wang J; Yang L; Liu J Life Sci; 2021 Apr; 271():119188. PubMed ID: 33581126 [TBL] [Abstract][Full Text] [Related]
33. Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses. Kang H; Kim C; Kim DE; Song JH; Choi M; Choi K; Kang M; Lee K; Kim HS; Shin JS; Kim J; Han SB; Lee MY; Lee SU; Lee CK; Kim M; Ko HJ; van Kuppeveld FJ; Cho S Antiviral Res; 2015 Dec; 124():1-10. PubMed ID: 26526589 [TBL] [Abstract][Full Text] [Related]
34. Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018. Han Y; Chen Z; Zheng K; Li X; Kong J; Duan X; Xiao X; Guo B; Luan R; Long L Pediatr Infect Dis J; 2020 Oct; 39(10):969-978. PubMed ID: 32433221 [TBL] [Abstract][Full Text] [Related]
35. Recent Progress on Functional Genomics Research of Enterovirus 71. Wang H; Li Y Virol Sin; 2019 Feb; 34(1):9-21. PubMed ID: 30552635 [TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Zhang G; Zhou F; Gu B; Ding C; Feng D; Xie F; Wang J; Zhang C; Cao Q; Deng Y; Hu W; Yao K Arch Virol; 2012 Apr; 157(4):669-79. PubMed ID: 22245989 [TBL] [Abstract][Full Text] [Related]
37. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice. Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182 [TBL] [Abstract][Full Text] [Related]
38. Efficient Blocking of Enterovirus 71 Infection by Heparan Sulfate Analogues Acting as Decoy Receptors. Earley DF; Bailly B; Maggioni A; Kundur AR; Thomson RJ; Chang CW; von Itzstein M ACS Infect Dis; 2019 Oct; 5(10):1708-1717. PubMed ID: 31307190 [TBL] [Abstract][Full Text] [Related]
39. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro. Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760 [TBL] [Abstract][Full Text] [Related]